We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00226265
First Posted: September 26, 2005
Last Update Posted: February 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mary E. Charlson, MD, Weill Medical College of Cornell University
September 14, 2005
September 26, 2005
February 23, 2017
January 1999
December 2006   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00226265 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients
The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Cardiac Surgery Patients at New York Presbyterian Hospital-Weill Cornell Medical College
  • Coronary Artery Bypass Grafting
  • Heart Diseases
  • Heart Valve Diseases
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
September 2007
December 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Cardiac surgery patients who are between the ages of 18 and 100
  • Are English speaking
  • Able to give consent
  • Undergoing cardiac surgery including (but not limited to):

    • Aortic valve replacement (AVR)
    • Mitral valve replacement (MVR)
    • Tricuspid valve replacement (TVR)
    • Coronary artery bypass graft (CABG).

Exclusion Criteria:

  • Non-cardiac surgery patients
Sexes Eligible for Study: All
18 Years to 100 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00226265
1203-069
No
Not Provided
Plan to Share IPD: No
Plan Description: No Plan to Share IPD
Mary E. Charlson, MD, Weill Medical College of Cornell University
Weill Medical College of Cornell University
Not Provided
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
Weill Medical College of Cornell University
February 2017